• Wednesday, June 25, 2025

Business

Glenmark Pharmaceuticals launches Tevimbra lung cancer immunotherapy in India, expands oncology portfolio

Glenmark Pharmaceuticals has officially launched Tevimbra (tislelizumab), a novel lung cancer treatment, in India following approval from the Central Drugs Standard Control Organisation (CDSCO). This launch marks Glenmark’s first foray…